CSL’s Strategy In FY2025 CSL continued to execute against the 2030 strategy. As the global landscape evolves rapidly, CSL is constantly evaluating how to build on its historical strength, developing a treatment pipeline through a mix of research and development, business development and commercialisation. The leading positions CSL has built across the Therapeutic Areas (refer to pages 20–23 to read more on these) puts CSL in a unique position to continue to deliver for patients and public health systems while also generating durable financial returns that support reinvestment in long-term growth and attractive shareholder returns. Underpinning the strategy are CSL Values: patient focus, innovation, integrity, collaboration and superior performance. The core elements of CSL’s strategy is shown right. ENDURING PATIENT IMPACT THERAPEUTIC AREAS VALUES FOCUS ON DELIVERING To deliver enduring patient impact in areas of high unmet medical need VALUES CSL Values are at the core of how employees interact with each other, make decisions and solve problems. PURPOSE The people and science of CSL save lives. CSL develops and delivers innovative medicines for patients who need durable, effective treatments for and protection from serious disease around the world. CSL Values guide the organisation in its aim of creating sustainable value for its stakeholders. Patient Focus Make people and patients your passion Integrity Walk your talk Innovation Reach for the unreachable Superior Performance Make yourself proud Collaboration Adventure together Our Strategic Ambition 10 Performance
RkJQdWJsaXNoZXIy MjE2NDg3